Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Jakesz, R; Hausmaninger, H; Samonigg, H; Kubista, E; Haider, K; Mlineritsch, B; Schmid, M; Tausch, C; Reiner, G; Renner, K; Stierer, M; Jatzko, G; Hofbauer, F; Fridrik, M; Schennach, W; Sevelda, P; Dadak, C; Haid, A; Scholz, R; Lenzhofer, P; Steindorfer, P; Berger, A; Mischinger, HJ.
Therapy studies of the Austrian Breast Cancer Group (ABC).
Zentralbl Chir. 1998; 123 Suppl 5:28-32
Web of Science
PubMed
- Co-Autor*innen der Med Uni Graz
- Mischinger Hans-Jörg
- Samonigg Hellmut
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- The Austrian Breast Cancer Group (ABC) consisting of more than 60 participating centers in Austria has randomized more than 5800 patients in 11 randomized trials since 1984. At present, roughly 30% of all patients with the diagnosis primary breast cancer are accrued in protocols throughout the country. Due to specific activities, the breast conservation rate raised from an initial 20% to more than 60% in the last years. Multicenter trials are not only the basis for progress in medicine but also tools for quality control and quality improvement.
- Find related publications in this database (using NLM MeSH Indexing)
- Antineoplastic Agents, Hormonal - therapeutic use
- Antineoplastic Combined Chemotherapy Protocols - therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -
- Breast Neoplasms - drug therapy Breast Neoplasms - mortality Breast Neoplasms - surgery
- Chemotherapy, Adjuvant -
- Combined Modality Therapy -
- Female -
- Humans -
- Mastectomy, Segmental -
- Neoplasms, Hormone-Dependent - drug therapy Neoplasms, Hormone-Dependent - mortality Neoplasms, Hormone-Dependent - surgery
- Randomized Controlled Trials as Topic -
- Survival Rate -
- Find related publications in this database (Keywords)
- breast cancer
- adjuvant chemotherapy
- adjuvant endocrine treatment
- high dose chemotherapy